» Articles » PMID: 20308885

Long-term Mortality and Quality of Life in Sepsis: a Systematic Review

Overview
Journal Crit Care Med
Date 2010 Mar 24
PMID 20308885
Citations 268
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Long-term outcomes from sepsis are poorly understood, and sepsis in patients may have different long-term effects on mortality and quality of life. Long-term outcome studies of other critical illnesses such as acute lung injury have demonstrated incremental health effects that persist after hospital discharge. Whether patients with sepsis have similar long-term mortality and quality-of-life effects is unclear.

Objective: We performed a systematic review of studies reporting long-term mortality and quality-of-life data (>3 months) in patients with sepsis, severe sepsis, and septic shock using defined search criteria.

Design: Systematic review of the literature.

Interventions: None.

Main Results: Patients with sepsis showed ongoing mortality up to 2 yrs and beyond after the standard 28-day inhospital mortality end point. Patients with sepsis also had decrements in quality-of-life measures after hospital discharge. Results were consistent across varying severity of illness and different patient populations in different countries, including large and small studies. In addition, these results were consistent within observational and randomized, controlled trials. Study quality was limited by inadequate control groups and poor adjustment for confounding variables.

Conclusions: Patients with sepsis have ongoing mortality beyond short-term end points, and survivors consistently demonstrate impaired quality of life. The use of 28-day mortality as an end point for clinical studies may lead to inaccurate inferences. Both observational and interventional future studies should include longer-term end points to better-understand the natural history of sepsis and the effect of interventions on patient morbidities.

Citing Articles

Pyrrolidine Dithiocarbamate Ameliorates Sepsis-Associated Encephalopathy by Inhibiting Autophagy and Inflammation in the Brain.

Lu Y, Zuo Z Neurochem Res. 2025; 50(2):106.

PMID: 40011296 PMC: 11865106. DOI: 10.1007/s11064-025-04355-5.


Health-Related Quality of Life Among Patients Who Have Survived an Episode of Sepsis in the United States: A Systematic Review.

Basu S, Wei Z, Laor A, Bennetts L, Ahmad N, El Khoury A Infect Dis Ther. 2025; 14(2):385-400.

PMID: 39862376 PMC: 11829873. DOI: 10.1007/s40121-024-01106-x.


Healthcare Professionals' Perspectives on Sepsis Care Pathways-Qualitative Pilot Expert Interviews.

Draeger L, Fleischmann-Struzek C, Bleidorn J, Kannengiesser L, Schmidt K, Apfelbacher C J Clin Med. 2025; 14(2).

PMID: 39860625 PMC: 11766067. DOI: 10.3390/jcm14020619.


Drp1-associated genes implicated in sepsis survival.

Pokharel M, Feng A, Liang Y, Ma W, Aggarwal S, Unwalla H Front Immunol. 2025; 15:1516145.

PMID: 39845954 PMC: 11750657. DOI: 10.3389/fimmu.2024.1516145.


Prevalence and Outcomes of Sepsis in Patients With Colon Carcinoma: Organism-Specific Analysis.

Iqbal R, Islam Z, Bajwa A, Mohammed Y, Kimball H, Samreen S Cureus. 2024; 16(11):e74175.

PMID: 39712755 PMC: 11663020. DOI: 10.7759/cureus.74175.